A NATIONAL PANEL FOR RESEARCH INTEGRITY:

1General Medical Council. Good Practice in Medical Research. Draft report of the ad hoc Working Group. March 2000.

2 Nimmo WS , editor. Joint Consensus Conference on Misconduct in Biomedical Research. Proc R Coll Physicians Edinb 2000; 30:Supplement 7.

3 Murray GD. Promoting good research practice. Stat Methods Med Res 2000; 9:17-24.

4 Ranstam J M Bayse George SL for the ISCB Subcommittee on Fraud. Fraud in medical research: an international survey of biostatisticians. Controlled Trials 2000; 21:415-27.

5Good Clinical Practice: The Tripartite Harmonised ICH Guidelines. Note for Guidance CPMP/768/97.

6 Hey E Chalmers I. Investigating allegations of research misconduct: the vital need for due process. Also: commentary by Griffiths R, Stacey TB, Struthers J. BMJ 2000; 321:752-6.

7 Yamey G. Protecting whistleblowers. BMJ 2000; 320:70-1.

8The Scottish Royal Colleges. ‘Guidance to members of external clinical advice teams (ECATs).’ June 2000.

9 Buyse M SL George Evans S for the ISCB Subcommittee on Fraud. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med 1999; 18: 3435-51.

10 Standard Operating Procedure for the Handling of Suspected Fraud. In: Lock S Wells F Farthing M editors. Fraud and Misconduct in Medical Research. 3rd ed. London: BMJ Publishing Group; 2001.